This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1977 Jan 1;1(8001):50-1.

doi: 10.1016/s0140-6736(77)91693-2.

Valproate may lower serum-phenytoin

P N Patsalos, P T Lascelles

PMID: 63694
DOI: 10.1016/s0140-6736(77)91693-2

Valproate may lower serum-phenytoin

P N Patsalos et al. Lancet. 1977.

. 1977 Jan 1;1(8001):50-1.

doi: 10.1016/s0140-6736(77)91693-2.

Authors

P N Patsalos, P T Lascelles

PMID: 63694
DOI: 10.1016/s0140-6736(77)91693-2

No abstract available

PubMed Disclaimer

Similar articles

Effect of sodium valproate on plasma protein binding of diphenylhydantoin.
Patsalos PN, Lascelles PT. Patsalos PN, et al. J Neurol Neurosurg Psychiatry. 1977 Jun;40(6):570-4. doi: 10.1136/jnnp.40.6.570. J Neurol Neurosurg Psychiatry. 1977. PMID: 20483 Free PMC article.
Valproate may lower serum-phenytoin.
Bardy A, Hari R, Lehtovaara R, Majuri H. Bardy A, et al. Lancet. 1976 Dec 11;2(7998):1297-8. doi: 10.1016/s0140-6736(76)92053-5. Lancet. 1976. PMID: 63764 No abstract available.
Valproate may lower serum-phenytoin.
Bardy A, Hari R, Lehtovaara R, Majuri H. Bardy A, et al. Lancet. 1977 Jun 11;1(8024):1256-7. doi: 10.1016/s0140-6736(77)92460-6. Lancet. 1977. PMID: 68349 No abstract available.
[Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
Fröscher W, Schulz HU, Gugler R. Fröscher W, et al. Fortschr Neurol Psychiatr Grenzgeb. 1978 Jun;46(6):327-41. Fortschr Neurol Psychiatr Grenzgeb. 1978. PMID: 352872 Review. German.
Clinical pharmacokinetics of sodium valproate, carbamazepine and phenytoin. Level-dose ration and interactions.
Levy RH, Moreland TA. Levy RH, et al. Schweiz Rundsch Med Prax. 1984 Feb 7;73(6):159-63. Schweiz Rundsch Med Prax. 1984. PMID: 6424205 Review. No abstract available.

See all similar articles

Cited by

Clinical pharmacokinetics of valproic acid.
Gugler R, von Unruh GE. Gugler R, et al. Clin Pharmacokinet. 1980 Jan-Feb;5(1):67-83. doi: 10.2165/00003088-198005010-00002. Clin Pharmacokinet. 1980. PMID: 6767575 Review. No abstract available.
Plasma protein binding interaction between phenytoin and valproic acid in vitro.
Monks A, Boobis S, Wadsworth J, Richens A. Monks A, et al. Br J Clin Pharmacol. 1978 Dec;6(6):487-92. doi: 10.1111/j.1365-2125.1978.tb00871.x. Br J Clin Pharmacol. 1978. PMID: 365209 Free PMC article.
Pharmacokinetic drug interactions with phenytoin (Part II).
Nation RL, Evans AM, Milne RW. Nation RL, et al. Clin Pharmacokinet. 1990 Feb;18(2):131-50. doi: 10.2165/00003088-199018020-00004. Clin Pharmacokinet. 1990. PMID: 2180613 Review. No abstract available.
Disposition of sodium valproate in epileptic patients.
Perucca E, Gatti G, Frigo GM, Crema A, Calzetti S, Visintini D. Perucca E, et al. Br J Clin Pharmacol. 1978 Jun;5(6):495-9. doi: 10.1111/j.1365-2125.1978.tb01663.x. Br J Clin Pharmacol. 1978. PMID: 350251 Free PMC article. Clinical Trial.
Effect of saliva flow rate on saliva phenytoin concentrations: implications for therapeutic monitoring.
Kamali F, Thomas SH. Kamali F, et al. Eur J Clin Pharmacol. 1994;46(6):565-7. doi: 10.1007/BF00196118. Eur J Clin Pharmacol. 1994. PMID: 7995328 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science